Geller Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,779
Closed -$457K 266
2023
Q3
$457K Sell
5,779
-1,512
-21% -$127K 0.05% 125
2023
Q2
$647K Buy
+7,291
New +$628K 0.08% 84
2022
Q3
Sell
-4,062
Closed -$367K 143
2022
Q2
$367K Buy
4,062
+7
+0.2% +$709 0.08% 71
2022
Q1
$452K Buy
4,055
+85
+2% +$8.98K 0.08% 64
2021
Q4
$413K Buy
3,970
+5
+0.1% +$579 0.08% 75
2021
Q3
$500K Sell
3,965
-203
-5% -$26.3K 0.11% 57
2021
Q2
$520K Sell
4,168
-2
-0% -$251 0.11% 51
2021
Q1
$495K Buy
4,170
+797
+24% +$93.4K 0.12% 50
2020
Q4
$452K Hold
3,373
0.11% 47
2020
Q3
$352K Sell
3,373
-251
-7% -$25.2K 0.1% 47
2020
Q2
$334K Buy
+3,624
New +$348K 0.1% 48

Other funds holding MDT

Geller Advisors's MDT Position: Q4 2023 in Review

Geller Advisors sold out of Medtronic (MDT) in Q4 2023, closing a stake of 5,779 shares — an estimated $457K sold.

Geller Advisors first reported a position in MDT in Q2 2020 and held it in 11 quarters. The position peaked at $647K in Q2 2023. 2,078 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Geller Advisors reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • Geller Advisors sold 5,779 Medtronic shares in Q4 2023, an estimated $457K.
  • Geller Advisors first reported a position in Medtronic in Q2 2020 and held it in 11 quarters.
  • Geller Advisors's Medtronic position peaked at $647K in Q2 2023.
  • 2,078 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Geller Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.